Making medical decisions in dependence of genetic background: estimation of the utility of DNA testing in clinical, pharmaco-epidemiological or genetic studies.

Abstract excerpt

An index measuring the utility of testing a DNA marker before deciding between two alternative treatments is proposed which can be estimated from pharmaco-epidemiological case-control or cohort studies. In the case-control design, external estimates of the prevalence of the disease and of the fre...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apolipoprotein A-II
• Share to Computer Simulation
• Share to Decision Support Systems, Clinical